Description

An advertisement for Lexapro a company that provides health plan formulations without restrictions. The advertisement features a photo of a woman with blonde hair and blue eyes smiling and looking off to the side. The background is blurred but it appears to be an outdoor setting with trees and greenery. The text on the advertisement reads "See the effect of LEXAPRO-3. Proven efficacy and tolerability in MDD and GAD. Prescribed to over 18 million US adults. Widely available on health plan formularizes without restrictions." At the bottom of the advertisement there is a logo for Forest Pharmaceuticals Inc. and the company's name and contact information.

Type

Information copied to your clipboard:

"An advertisement for Lexapro a company that provides health plan formulations without restrictions. The advertisement features a photo of a woman wit...

Related Images

A timeline of the FDA approval process and manufacturing of for a product possibly fentanyl. The timeline goes from 3/15/12 to 9/3/12. It includes items (in no particular order) such as: BE Study FDA Response; BE Study FDA Audit Results; Fentanyl 12 FDA Review Restart; FDA Approval; $60k printed and Long Lead Time Materials; Pouch Fabrication PV Lots; Stability Studies; and Launch. The timeline is color coded to indicate when a risk occurrence level is medium low or remote.

Facebook X LinkedIn Pinterest Email

A 3D rendering of a protein molecule with the letter "Y" in the top left corner. The molecule is in the center of the image and is surrounded by a blue background. On the right side there is a small round metallic object with green and red dots on its surface. The object appears to be a cell or a protein and it is flying towards the left side of the molecule. The background is blurred but it seems like the molecule is floating in the air. The molecules are arranged in a way that they are connected to each other creating a network-like structure.

Facebook X LinkedIn Pinterest Email

A 3D computer drawing of a vendor exhibition space (presumably) for Mallinckrodt Pharmaceuticals. The bird's-eye view shows a large table (at top left) smaller tables (at bottom left) and a seating area with 15 chairs (at bottom right). The background (that is the floor) is light brown (suggesting wood parquet flooring) with furniture and fixtures in white and gray.

Facebook X LinkedIn Pinterest Email

$A diagram in the shape of a staircase. The left half of the staircase is labeled "Analgesics" and the right half of the staircase is labeled "Interventional Therapies." For the analgesics side the bottom step reads "Non-opioid analgesics + adjuvant" the second step reads "Weak opioids +/- non-opioid analgesics + adjuvant" and the third steps reads "Strong opioids + non-opioid analgesics + adjuvant". The words "refractory pain" are between each step. <br /><br />For the interventional therapies side of the staircase there is a block sitting on each step each of which has a label. The block on the bottom step reads "Diagnostic Blocks Epidural steroids Radiofrequency techniques". The block on the second step reads "Neurostimulation techniques" and the block on the top step reads "Neuraxial medication".$